Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Deutsche Bank employees across the UK raised this generous sum via their ‘One Day’ initiative, in collaboration with Cure Leukaemia

On Thursday 27th September, in Blood Cancer Awareness Month, Deutsche Bank employees across the UK were invited to donate a day’s salary to its two UK Charities of the Year through the bank’s ‘One Day’ initiative. The day was a huge success with a record £1.27m raised, with Cure Leukaemia receiving half of these funds in total (£100,000 more than the charity raised in an entire year back in 2012).

The £635,000 raised will help finance a pioneering Therapy Acceleration Laboratory at the MRC Weatherall Institute of Molecular Medicine, which will drive the development of new approaches to human disease, including personalised blood cancer therapies.

Read more (MRC WIMM website)

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.

Professor Hugh Watkins wins £30 million research award to cure killer heart diseases

The British Heart Foundation award aims to help researchers rewrite DNA, in “defining moment” for cardiovascular medicine.

Six RDM research groups secure LEAF Sustainability Awards

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.

Ewa Gogola receives Wellcome Early Career Award

Dr Ewa Gogola from the Patel Group in the MRC Molecular Haematology Unit has been awarded funding by the Wellcome Trust for the project ‘DNA damage-induced hepatocyte polyploidisation- how it happens and what are its consequences?’